<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03457077</url>
  </required_header>
  <id_info>
    <org_study_id>7390</org_study_id>
    <nct_id>NCT03457077</nct_id>
  </id_info>
  <brief_title>Neural and Mobile Assessment OF Behavior Change Among Problem Drinkers</brief_title>
  <official_title>Neural and Mobile Assessment OF Behavior Change Among Problem Drinkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the neural mechanisms underlying both spontaneous behavior change and&#xD;
      behavior change in response to a brief intervention among problem drinkers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although problem drinkers (PD) are a less severe, highly prevalent sub-type of alcohol use&#xD;
      disorder (AUD) who are more likely to undergo reductions in alcohol use, compared to more&#xD;
      severe AUD, the underlying mechanisms that maintain PD, as well as the mechanisms that&#xD;
      underlie both spontaneous and treatment- related behavior change in this population, are not&#xD;
      well understood. This proposal takes a lab to life approach by combining functional&#xD;
      neuroimaging (fMRI), ecological momentary assessment (EMA), and brief interventions (BI) in&#xD;
      non-treatment seeking PD to test whether heightened incentive salience (reactivity) to&#xD;
      alcohol cues and impaired ability to regulate cue-induce craving are the mechanisms that&#xD;
      characterize PD, and play a role in behavior change vs. persistence of behavior. Identifying&#xD;
      these mechanisms is critical for testing and understanding treatments and uncovering who is&#xD;
      most likely to respond to interventions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 27, 2018</start_date>
  <completion_date type="Anticipated">February 27, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 27, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Drinking</measure>
    <time_frame>6 months</time_frame>
    <description>Heavy drinking days</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <arm_group>
    <arm_group_label>Brief Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive a brief intervention at week 0</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will receive a brief intervention at 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief intervention</intervention_name>
    <description>A brief motivational intervention with feedback about drinking levels compared to norms</description>
    <arm_group_label>Brief Intervention</arm_group_label>
    <arm_group_label>Delayed Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (Problem Drinkers):&#xD;
&#xD;
          -  Age 21-55&#xD;
&#xD;
          -  English language fluency&#xD;
&#xD;
          -  Over the last 28 days ,Have an average weekly consumption of greater than 14 standard&#xD;
             drinks for women, and greater than 24 standard drinks for men.&#xD;
&#xD;
          -  Current DSM-V mild or moderate alcohol use disorder (AUD) diagnosis&#xD;
&#xD;
          -  Own a smartphone with data plan&#xD;
&#xD;
        Inclusion Criteria (Healthy Controls):&#xD;
&#xD;
          -  Age 21-55&#xD;
&#xD;
          -  English language fluency&#xD;
&#xD;
          -  Have an average weekly consumption of less than &lt;/=14 standard drinks for women and&#xD;
             less than/equal to 24 standard drinks for men and up to 2 heavy drinking days (&gt;4/5&#xD;
             standard drinks for a woman/man)&#xD;
&#xD;
          -  No lifetime diagnosis of AUD&#xD;
&#xD;
          -  owns smartphone with a data plan&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Past or current severe AUD as defined by DSM- V&#xD;
&#xD;
          -  Currently seeking treatment or attempting to stop drinking&#xD;
&#xD;
          -  Past or current alcohol withdrawal symptoms&#xD;
&#xD;
          -  Current DSM-V diagnosis of substance use disorder (other than nicotine or caffeine).&#xD;
&#xD;
          -  Regular use (more than 1-2 times weekly) of recreational drugs.&#xD;
&#xD;
          -  Psychotic Disorder or Bipolar disorder&#xD;
&#xD;
          -  Severe depression (Patient Health Questionnaire score &gt; 19) or anxiety (Beck Anxiety&#xD;
             Inventory &gt; 25)&#xD;
&#xD;
          -  Substantial risk of suicide or violence&#xD;
&#xD;
          -  MRI contraindications (e.g., metallic implants, pacemaker, weight &gt; 350 lbs, waist &gt;&#xD;
             55&quot;)&#xD;
&#xD;
          -  Hearing impaired/hearing aids, unable to read newspaper at arm's length with&#xD;
             corrective&#xD;
&#xD;
          -  Objective cognitive impairment&#xD;
&#xD;
          -  Current or recent (evidence of disease x 5 years) non-skin neoplastic disease or&#xD;
             melanoma. - Active hepatic disease (not a history of hepatitis) or primary renal&#xD;
             disease requiring dialysis, primary untreated endocrine diseases, e.g., Cushing's&#xD;
             disease or primary hypothalamic failure or insulin dependent diabetes (Type I or II).&#xD;
             Well-treated hypothyroidism will not be excluded.&#xD;
&#xD;
          -  Pregnant, lactating (participation allowed 3 months after ceasing lactation), or&#xD;
             currently intending to become pregnant&#xD;
&#xD;
          -  Any history of ECT&#xD;
&#xD;
          -  Brain disorder such as stroke, tumor, infection, epilepsy, multiple sclerosis,&#xD;
             degenerative diseases, head injury (LOC &gt; 5 minutes), mental retardation&#xD;
&#xD;
          -  Diagnosed learning disability, dyslexia, or ADHD&#xD;
&#xD;
          -  For women: Current pregnancy or intention to be pregnant in the near future&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nasir Naqvi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nasir Naqvi, MD, PhD</last_name>
    <phone>(212) 923-3031</phone>
    <email>nhn2102@cumc.columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amy Mahony</last_name>
    <phone>6467748183</phone>
    <email>amy.mahony@nyspi.columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NYPInstitute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nasir H. Naqvi, MD, PhD</last_name>
      <phone>212-923-3031</phone>
      <email>nhn2102@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Nasir H. Naqvi, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York State Psychiatric Institute</investigator_affiliation>
    <investigator_full_name>Nasir Naqvi</investigator_full_name>
    <investigator_title>research psychiatrist</investigator_title>
  </responsible_party>
  <keyword>brief intervention</keyword>
  <keyword>fMRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

